1Chin KM, Rubin LJ. Pulmonar)' arterial hypertension. J Am Coil Cardiol, 2008, 51: 1527-1538.
2Gali N, Manes A, Negro L, et al. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J 2009, 30: 394-403.
3Thenappan T, Shah SJ, Rich S, et al. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J, 2007, 30: 1103-1110.
4Hoeper MM, Markevych I, Spiekerkoetter E, et al. Goal-oriented treatment and combination therapy for pulmonary arterial hypertension. Eur Respir J, 2005, 26: 858-863.
5Nishimura T, Faul JL, Berry GJ, et al. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats. Am J Respir Crit Care Med, 2002, 166: 1403-1408.
6Ha H, Sung A, Zhao GH, et al. Simvastatin enhances bone morphogenetic protein receptor type 1 expression. Bichem Biophs Res Commun, 2006, 339: 59-64.
7Hsu HH, Ko WJ, Hsu JY, et al. Simvastatin ameliorates established pulmonary hypertension through a heme oxygenase-I dependent pathway in rats. Respir Res, 2009, 10: 32.
8Itoh T, Nagaya N, Fujii T, et al. A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats. Am J Respir Crit Care Med, 2004, 169: 34-38.
9Nagaoka T, Fagan KA, Gebb SA, et al. Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension. Am J Respir Crit Care Med, 2005, 171 : 494-499.
10King WT, Day RW. Treatment of pediatric pulmonary hypertension with simvastatin: An observational study. Pediatr Puhnonol, 2011, 46: 261-265.
